JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SASR
4176
DELISTED
Sandy Spring Bancorp Inc
SASR
| $5K | ﹤0.01% |
185
-2
| -1% | -$53 |
2015 Q4
1 quarter
|
|
|
HAYN
4177
DELISTED
Haynes International, Inc.
HAYN
| $5K | ﹤0.01% |
+130
| New | +$4.27K |
2016 Q1
0 quarters
|
|
|
ALIM
4178
DELISTED
Alimera Sciences
ALIM
| $5K | ﹤0.01% |
193
-40
| -17% | -$1.25K |
2015 Q4
1 quarter
|
|
|
CCLP
4179
DELISTED
CSI Compressco LP
CCLP
| $5K | ﹤0.01% |
+800
| New | +$4.88K |
2016 Q1
0 quarters
|
|
|
CYTO
4180
DELISTED
Altamira Therapeutics Ltd
CYTO
| – | – |
0
| – | – |
2016 Q1
0 quarters
|
|
|
IBA
4181
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $5K | ﹤0.01% |
98
| – | – |
2015 Q4
1 quarter
|
|
|
LCI
4182
DELISTED
Lannett Company, Inc.
LCI
| $5K | ﹤0.01% |
66
-12
| -15% | -$1.27K |
2015 Q4
1 quarter
|
|
|
FNI
4183
DELISTED
First Trust Chindia ETF
FNI
| $5K | ﹤0.01% |
187
-8,686
| -98% | -$221K |
2014 Q3
6 quarters
|
|
|
JMEI
4184
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $5K | ﹤0.01% |
73
-426
| -85% | -$27.5K |
2015 Q4
1 quarter
|
|
|
ISCA
4185
DELISTED
International Speedway Corp
ISCA
| $5K | ﹤0.01% |
122
-173
| -59% | -$5.9K |
2015 Q4
1 quarter
|
|
|
IPCC
4186
DELISTED
Infinity Property & Casualty C
IPCC
| $5K | ﹤0.01% |
60
| – | – |
2015 Q4
1 quarter
|
|
|
BAA
4187
DELISTED
Banro Corporation Common Stock
BAA
| $5K | ﹤0.01% |
1,874
| – | – |
2013 Q2
11 quarters
|
|
|
PTX
4188
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $5K | ﹤0.01% |
432
+374
| +645% | +$7.43K |
2015 Q4
1 quarter
|
|
|
RDEN
4189
DELISTED
ELIZABETH ARDEN INC
RDEN
| $5K | ﹤0.01% |
571
+374
| +190% | +$2.65K |
2015 Q4
1 quarter
|
|
|
CRWN
4190
DELISTED
CROWN MEDIA HOLDINGS INC CL-A
CRWN
| $5K | ﹤0.01% |
+919
| New | +$4.32K |
2016 Q1
0 quarters
|
|
|
ULQ
4191
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
| $5K | ﹤0.01% |
103
+3
| +3% | +$146 |
2015 Q3
2 quarters
|
|
|
SVA
4192
DELISTED
Sinovac Biotech, Ltd
SVA
| $5K | ﹤0.01% |
781
+220
| +39% | +$1.32K |
2015 Q4
1 quarter
|
|
4193
Braskem
BAK
$657M
| $4K | ﹤0.01% |
319
+20
| +7% | +$255 |
2015 Q3
2 quarters
|
|
|
CCM
4194
Concord Medical Services
CCM
$13.5M
| $4K | ﹤0.01% |
+80
| New | +$3.78K |
2016 Q1
0 quarters
|
|
4195
Chegg
CHGG
$81.6M
| $4K | ﹤0.01% |
1,000
-50,891
| -98% | -$258K |
2013 Q4
9 quarters
|
|
4196
iShares MSCI Chile ETF
ECH
$969M
| $4K | ﹤0.01% |
101
+1
| +1% | +$33 |
2013 Q2
11 quarters
|
|
4197
Exelixis
EXEL
$14.6B
| $4K | ﹤0.01% |
+944
| New | +$4K |
2016 Q1
0 quarters
|
|
4198
FirstService
FSV
$5.6B
| $4K | ﹤0.01% |
105
-4,032
| -97% | -$153K |
2015 Q4
1 quarter
|
|
|
GOGL
4199
DELISTED
Golden Ocean Group
GOGL
| $4K | ﹤0.01% |
1,210
+202
| +20% | +$691 |
2015 Q3
2 quarters
|
|
|
LNW
4200
DELISTED
Light & Wonder
LNW
| $4K | ﹤0.01% |
412
-574
| -58% | -$4.28K |
2013 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.